The latter results in more pronounced hypoglycemia in ChREBP-normalized hepatic GSD Ib mice, which in turn increases the glucagon/insulin ratio, that subsequently enhances the flux through hepatic glycogen phosphorylase. This evidence concerns the gene GCG and disorder of glycogen metabolism.